Can I read CCL26 and CCR3 as LEAD Biomarkers in T2DM on EtoBox?

CCL26 and CCR3 as LEAD Biomarkers in T2DM by renjupaulin is a document available to read on EtoBox.

What is CCL26 and CCR3 as LEAD Biomarkers in T2DM about?

This study investigates the serum levels of Chemokine CCL26 and Receptor CCR3 in patients with Type 2 Diabetes Mellitus (T2DM) and lower extremity artery disease (LEAD), finding elevated levels in the LEAD group. The research identifies CCL26 and CCR3 as potential diagnostic biomarkers for LEAD, with a high predictive value demonstrated through statistical analysis. The findings suggest that these biomarkers are closely associated with the occurrence of LEAD in T2DM patients, highlighting their significance

Author

renjupaulin

Language

EN